$183 Million is the total value of RHO CAPITAL PARTNERS INC's 10 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANAC | ANACOR PHARMACEUTICALS INC | $57,079,000 | -52.7% | 1,067,892 | 0.0% | 31.25% | -24.7% | |
| IL | INTRALINKS HLDGS INC | $49,569,000 | -13.1% | 6,290,503 | 0.0% | 27.14% | +38.4% | |
| EVDY | EVERYDAY HEALTH INC | $23,002,000 | -7.0% | 4,107,522 | 0.0% | 12.60% | +48.1% | |
| ITEK | INOTEK PHARMACEUTICALS CORP | $19,446,000 | -34.7% | 2,627,790 | 0.0% | 10.65% | +4.0% | |
| CARA | Buy | CARA THERAPEUTICS INC | $19,083,000 | -57.6% | 3,068,057 | +15.0% | 10.45% | -32.4% |
| RUBI | Sell | RUBICON PROJ INC | $7,995,000 | +4.2% | 437,390 | -6.3% | 4.38% | +65.9% |
| RLOC | REACHLOCAL INC | $4,601,000 | +8.5% | 2,570,395 | 0.0% | 2.52% | +72.8% | |
| SENS | New | SENSEONICS HLDGS INC | $1,324,000 | – | 462,794 | +100.0% | 0.72% | – |
| NRXGQ | NEPHROGENEX INC | $495,000 | -70.6% | 1,052,966 | 0.0% | 0.27% | -53.2% | |
| XCOMQ | XTERA COMMUNICATIONS INC | $38,000 | -36.7% | 13,366 | 0.0% | 0.02% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CARA THERAPEUTICS INC | 31 | Q3 2021 | 92.2% |
| SENSEONICS HLDGS INC | 30 | Q3 2023 | 1.5% |
| MERSANA THERAPEUTICS INC | 22 | Q3 2022 | 23.4% |
| INTRALINKS HLDGS INC | 15 | Q4 2016 | 65.2% |
| LIVEXLIVE MEDIA INC | 15 | Q3 2021 | 26.2% |
| REACHLOCAL INC | 13 | Q2 2016 | 27.5% |
| NGM BIOPHARMACEUTICALS INC | 12 | Q1 2022 | 60.1% |
| ANACOR PHARMACEUTICALS INC | 12 | Q1 2016 | 41.8% |
| EVERYDAY HEALTH INC | 11 | Q3 2016 | 42.4% |
| CHARGEPOINT HOLDINGS INC | 10 | Q3 2023 | 98.7% |
View RHO CAPITAL PARTNERS INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| GENVEC INC | March 04, 2011 | ? | ? |
| Anacor Pharmaceuticals Inc | December 10, 2010 | 5,621,423 | 21.1% |
| VERENIUM CORP | October 23, 2009 | 196,835 | 1.7% |
| NITROMED INCSold out | May 01, 2009 | 0 | 0.0% |
| TERCICA INC | October 24, 2008 | ? | ? |
| AUTO DATA NETWORK | February 14, 2008 | 18,879 | 0.0% |
| CYBERONICS INC | February 14, 2008 | 204,837 | 0.7% |
| CAPSTONE TURBINE CORP | February 13, 2007 | 1,627,176 | 1.6% |
| SENOMYX INC | February 01, 2006 | 67,317 | 0.3% |
| ENHERENT CORP | September 28, 2005 | 1,103,380 | 2.2% |
View RHO CAPITAL PARTNERS INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-01 |
| 13F-HR | 2022-05-11 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-13 |
View RHO CAPITAL PARTNERS INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.